Antigon raises €1.5m to CE mark portable blood transfusion security device ISABO

December 22nd 2021


Antigon SA, which is developing ISABO, a portable device for ultimate safety and traceability of blood transfusions via double verification, has raised €1.5m to help it finalize development and support a European CE mark submission. In the fundraising round, which achieved more than twice its original target, existing investors Sambrinvest and BeAngels are joined by laboratory solutions company Analis SA and plastic injection moulder HTP Europe. Proceeds will also be used to finalize ISABO’s development and expand the team, particularly in sales, clinical and technical development in advance of product launch in 2023. Antigon estimates the size of its market to be €200m per year worldwide. 

Read Pdf